Skip to content
healthcare.dev
Get a free key

alogliptin and metformin hydrochloride

NDC 45802-169, alogliptin and metformin hydrochloride, tablet, film coated, from Padagis Israel Pharmaceuticals Ltd.

Product NDC
45802-169
Status
Listed
Labeler
Padagis Israel Pharmaceuticals Ltd
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA AUTHORIZED GENERIC
Application
NDA203414
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/45802-169 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ALOGLIPTIN BENZOATE12.5 mg/1
  • METFORMIN HYDROCHLORIDE500 mg/1

Pharmacologic classes

Biguanide [EPC]; Biguanides [CS]; Dipeptidyl Peptidase 4 Inhibitor [EPC]; Dipeptidyl Peptidase 4 Inhibitors [MoA]

Package NDCNDC-11Package
45802-169-724580201697260 TABLET, FILM COATED in 1 BOTTLE (45802-169-72)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/14d98490-4f8f-4d2f-a4e9-7a3d7a0199ba

  • NADAC price for package 45802016972

    GET /v1/drugs/nadac/45802016972

Use it

Look up 45802-169 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/45802-169 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 45802-169. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.